(Q34452574)

English

Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

stem cell transplantation

1 reference

based on heuristic

inferred from title

object named as

Ingo Müller

9

1 reference

ORCID Public Data File 2021

author name string

Michaela Döring

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Carsten Müller

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Pascal-David Johann

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Annika Erbacher

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Astrid Kimmig

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Carl-Philipp Schwarze

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Peter Lang

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Rupert Handgretinger

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

19 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

BMC Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

263

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

19 October 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

https://scigraph.springernature.com/pub.10.1186/1471-2334-12-263

0 references

Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514296

6 July 2018

Posaconazole exposure-response relationship: evaluating the utility of therapeutic drug monitoring

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514296

6 July 2018

Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514296

6 July 2018

Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514296

6 July 2018

Treatment of invasive candidiasis in immunocompromised pediatric patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514296

6 July 2018

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514296

6 July 2018

Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: a pilot study for evaluation of safety and efficacy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514296

6 July 2018

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514296

6 July 2018

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514296

6 July 2018

Posaconazole plasma concentrations in juvenile patients with invasive fungal infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514296

6 July 2018

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514296

6 July 2018

Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514296

6 July 2018

Posaconazole as Salvage Treatment for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other Conditions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514296

6 July 2018

Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514296

6 July 2018

Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514296

6 July 2018

Disposition of posaconazole following single-dose oral administration in healthy subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514296

6 July 2018

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514296

6 July 2018

Prevention of fungal infections in children and adolescents with cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-263

21 January 2018

Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-263

21 January 2018

Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-263

21 January 2018

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-263

21 January 2018

Posaconazole salvage treatment in paediatric patients: a multicentre survey

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-263

21 January 2018

Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-263

21 January 2018

Retrospective survey on the off-label use of posaconazole in pediatric hematology patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23082876

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HPLC analysis of the antifungal agent posaconazole in patients with haematological diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/23082876

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2334-12-263

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34452574&oldid=1800381093"